Prevalence of Use Study for Amphetamine (AMP), Methamphetamine (MAMP), 3,4-Methylenedioxyamphetamine (MDA) 3,4-Methylenedioxymethamphetamine (MDMA), and 3,4-Methylenedioxyethylamphetamine (MDEA) in Military Entrance Processing Stations (MEPS) Specimens
Journal of Analytical Toxicology June 1, 2006 K. L. Klette, A. R. Kettle, M. H. Jamerson 13 citations
The Roche Abuscreen Onlinetrade mark Amphetamine immunoassay (IA), modified to include sodium periodate, and the Microgenics DRI Ecstasy IA were used to determine the prevalence of amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) in urine specimens from applicants seeking to...
DOI: 10.1093/jat/30.5.319 (opens in new tab)
Full text (opens in new tab)
MDMA
Ecstasy
Methamphetamine
Chromatography
+2